Send to

Choose Destination
Free Radic Biol Med. 2010 Jul 15;49(2):144-6. doi: 10.1016/j.freeradbiomed.2010.04.009. Epub 2010 Apr 24.

The Nrf2 pathway as a potential therapeutic target for Huntington disease A commentary on "Triterpenoids CDDO-ethyl amide and CDDO-trifluoroethyl amide improve the behavioral phenotype and brain pathology in a transgenic mouse model of Huntington disease".

Author information

CEA, DSV, I2BM, Molecular Imaging Research Center, F-92265 Fontenay-aux-Roses, France.
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center